# CHN2

## Overview
The CHN2 gene encodes the β2-chimaerin protein, a GTPase-activating protein (GAP) that plays a pivotal role in cellular signaling by regulating the activity of Rac1, a member of the Rho family of GTPases. β2-chimaerin is characterized by its ability to bind diacylglycerol (DAG) and phorbol esters through its C1 domain, facilitating its translocation to the plasma membrane and activation. This protein is integral to processes such as cytoskeletal organization, cell migration, and cellular homeostasis, and is particularly important in the context of neuronal development and cancer biology. The CHN2 gene is subject to alternative splicing, resulting in various isoforms with distinct functional properties. Alterations in CHN2 expression and function have been implicated in several diseases, including cancer, diabetic retinopathy, and addiction, underscoring its clinical significance (GutierrezUzquiza2013Coordinated; BarrioReal2013Association; CALOCA2003Characterization).

## Structure
The CHN2 gene encodes the β2-chimaerin protein, which is a GTPase-activating protein (GAP) for Rac, a member of the Rho family of GTPases. The protein structure includes several key domains: a conserved GAP domain that facilitates GTP hydrolysis by Rac, and a C1 domain that binds diacylglycerol (DAG) and phorbol esters, crucial for membrane translocation and activation (GutierrezUzquiza2013Coordinated; Caloca1999β2Chimaerin). The C1 domain shares structural similarities with the C1b domain of protein kinase C (PKC), including conserved residues for zinc coordination and hydrophobic core formation (Caloca1999β2Chimaerin).

β2-chimaerin also features a proline-rich region that interacts with the third SH3 domain of the adaptor protein Nck1, which is essential for its translocation to the plasma membrane and activation (GutierrezUzquiza2013Coordinated). This interaction is atypical as it does not follow the typical PxxP motif, instead involving basic residues in the motif PRPKR (GutierrezUzquiza2013Coordinated).

Alternative splicing of the CHN2 gene results in different isoforms, such as β1-Δ7p-chimaerin, which lacks a functional C1 domain and localizes to the nucleus due to a nuclear localization signal (CasadoMedrano2019Identification). This variant is unresponsive to DAG and phorbol esters, distinguishing it from other isoforms (CasadoMedrano2019Identification).

## Function
CHN2, also known as chimerin 2, encodes a GTPase-activating protein (GAP) that plays a critical role in regulating the activity of Rac1, a small GTPase involved in various cellular processes. β2-chimaerin, the protein product of CHN2, functions by accelerating the hydrolysis of GTP bound to Rac1, thereby inactivating it and controlling Rac1 signaling pathways. This regulation is essential for processes such as cytoskeletal organization, cell migration, and cellular homeostasis (CALOCA2003Characterization).

β2-chimaerin is activated by diacylglycerol (DAG) and interacts with the adaptor protein Nck1, which is crucial for its translocation to the plasma membrane and subsequent interaction with Rac1. This interaction is necessary for the proper functioning of β2-chimaerin in cellular signaling, particularly in response to epidermal growth factor receptor (EGFR) stimulation (GutierrezUzquiza2013Coordinated).

In the context of cerebellar development, β2-chimaerin is essential for the migration of granule cells. Its deficiency leads to migration defects, resulting in ectopic neuronal clusters, highlighting its role in proper neuronal positioning and development (Estep2018The). The protein is active in the cytoplasm and is involved in maintaining cellular and organismal homeostasis by regulating Rac1 activity (CALOCA2003Characterization).

## Clinical Significance
Mutations and alterations in the expression of the CHN2 gene have been linked to several diseases and conditions. In cancer, β2-chimaerin, a protein encoded by CHN2, acts as a tumor suppressor by inhibiting Rac activity, which is crucial for cell proliferation and adhesion. Reduced levels of β2-chimaerin have been observed in various cancers, including breast cancer, colorectal cancer, and malignant gliomas, suggesting its downregulation may contribute to tumorigenesis and metastasis (beta; 2Chimaerin; Bruinsma2007&amp). 

In colorectal cancer, alterations in the methylation status of CHN2 have been associated with poorer survival outcomes, indicating its potential as a prognostic marker (Zhang2021A). The CHN2 gene has also been implicated in diabetic retinopathy, with specific single nucleotide polymorphisms (SNPs) showing significant associations with the condition in Chinese type 2 diabetic patients (Hu2011CPVLCHN2).

Additionally, CHN2 variants have been linked to addiction vulnerability, particularly smoking behavior, with certain polymorphisms being more frequent in smokers, suggesting a genetic influence on tobacco addiction (BarrioReal2013Association). These findings highlight the clinical significance of CHN2 in various pathological conditions.

## Interactions
CHN2, also known as β2-chimaerin, is involved in several protein-protein interactions that are crucial for its function in intracellular signaling pathways. One of the key interactions is with the adaptor protein Nck1. This interaction is mediated by an atypical proline-rich motif, PRPKR, in β2-chimaerin, which binds to the third SH3 domain of Nck1. This binding is essential for the translocation of β2-chimaerin to the plasma membrane and its subsequent activation in response to epidermal growth factor receptor (EGFR) stimulation (GutierrezUzquiza2013Coordinated).

The interaction between β2-chimaerin and Nck1 is characterized by electrostatic interactions, where the positively charged residues in the PRPKR motif complement the negatively charged surface of the Nck1 SH3-3 domain. This interaction is crucial for the structural rearrangement of β2-chimaerin, allowing it to bind in its open, active conformation (GutierrezUzquiza2013Coordinated).

β2-chimaerin also interacts with Rac1, a small GTPase, to regulate actin cytoskeleton dynamics. It acts as a GTPase-activating protein (GAP) for Rac1, promoting GTP hydrolysis and leading to Rac1 inactivation. This interaction is enhanced by acidic phospholipids and is crucial for reducing cellular Rac-GTP levels, particularly in response to EGF stimulation (CALOCA2003Characterization).


## References


[1. (BarrioReal2013Association) Laura Barrio-Real, Miguel Barrueco, Rogelio González-Sarmiento, and María J. Caloca. Association of a novel polymorphism of the β2-chimaerin gene (chn2) with smoking. Journal of Investigative Medicine, 61(7):1129–1131, October 2013. URL: http://dx.doi.org/10.2310/JIM.0b013e3182a32ff9, doi:10.2310/jim.0b013e3182a32ff9. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.2310/JIM.0b013e3182a32ff9)

[2. (GutierrezUzquiza2013Coordinated) Alvaro Gutierrez-Uzquiza, Francheska Colon-Gonzalez, Thomas A. Leonard, Bertram J. Canagarajah, HongBin Wang, Bruce J. Mayer, James H. Hurley, and Marcelo G. Kazanietz. Coordinated activation of the rac-gap β2-chimaerin by an atypical proline-rich domain and diacylglycerol. Nature Communications, May 2013. URL: http://dx.doi.org/10.1038/ncomms2834, doi:10.1038/ncomms2834. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms2834)

[3. (Estep2018The) Jason A. Estep, Wenny Wong, Yiu-Cheung E. Wong, Brian M. Loui, and Martin M. Riccomagno. The racgap β-chimaerin is essential for cerebellar granule cell migration. Scientific Reports, January 2018. URL: http://dx.doi.org/10.1038/s41598-017-19116-w, doi:10.1038/s41598-017-19116-w. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-19116-w)

[4. (CasadoMedrano2019Identification) Victoria Casado-Medrano, Laura Barrio-Real, Laura Gutiérrez-Miranda, Rogelio González-Sarmiento, Eladio A. Velasco, Marcelo G. Kazanietz, and María J. Caloca. Identification of a truncated β1-chimaerin variant that inactivates nuclear rac1. Journal of Biological Chemistry, 295(5):1300–1314, December 2019. URL: http://dx.doi.org/10.1074/jbc.ra119.008688, doi:10.1074/jbc.ra119.008688. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.008688)

[5. (Hu2011CPVLCHN2) Cheng Hu, Rong Zhang, Weihui Yu, Jie Wang, Congrong Wang, Can Pang, Xiaojing Ma, Yuqian Bao, Kunsan Xiang, and Weiping Jia. Cpvl/chn2 genetic variant is associated with diabetic retinopathy in chinese type 2 diabetic patients. Diabetes, 60(11):3085–3089, October 2011. URL: http://dx.doi.org/10.2337/db11-0028, doi:10.2337/db11-0028. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.2337/db11-0028)

[6. (CALOCA2003Characterization) Maria Jose CALOCA, HongBin WANG, and Marcelo G. KAZANIETZ. Characterization of the rac-gap (rac-gtpase-activating protein) activity of β2-chimaerin, a ‘non-protein kinase c’ phorbol ester receptor. Biochemical Journal, 375(2):313–321, October 2003. URL: http://dx.doi.org/10.1042/bj20030727, doi:10.1042/bj20030727. This article has 77 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20030727)

[7. (Caloca1999β2Chimaerin) Maria José Caloca, Maria Laura Garcia-Bermejo, Peter M. Blumberg, Nancy E. Lewin, Elisabeth Kremmer, Harald Mischak, Shaomeng Wang, Kassoum Nacro, Bruno Bienfait, Victor E. Marquez, and Marcelo G. Kazanietz. Β2-chimaerin is a novel target for diacylglycerol: binding properties and changes in subcellular localization mediated by ligand binding to its c1 domain. Proceedings of the National Academy of Sciences, 96(21):11854–11859, October 1999. URL: http://dx.doi.org/10.1073/pnas.96.21.11854, doi:10.1073/pnas.96.21.11854. This article has 82 citations.](https://doi.org/10.1073/pnas.96.21.11854)

[8. (Zhang2021A) Lei Zhang, Dapeng Li, Fenqi Du, Hao Huang, Chao Yuan, Jinming Fu, Simin Sun, Tian Tian, Xinyan Liu, Hongru Sun, Lin Zhu, Jing Xu, Yanlong Liu, Binbin Cui, and Yashuang Zhao. A panel of differentially methylated regions enable prognosis prediction for colorectal cancer. Genomics, 113(5):3285–3293, September 2021. URL: http://dx.doi.org/10.1016/j.ygeno.2021.07.010, doi:10.1016/j.ygeno.2021.07.010. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2021.07.010)